首页>
外国专利>
-20 -2 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
-20 -2 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
展开▼
机译：带有选择性BCL-2抑制剂的II型抗CD20抗体的-20 -2联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a combination therapy comprising a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of patients suffering from cancer, in particular CD20-expressing cancer.
展开▼
